CMS certification 190098
Ochsner LSU Health Shreveport
1541 Kings Highway, Shreveport, LA 71130
Ochsner LSU Health Shreveport has a CMS overall rating of 2 out of 5 stars. 69% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 21 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on none. Emergency patients spend a median of 4 h 7 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 548 completed surveys, 15% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | LA | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 283 visits sampled · US median for EDs of the same volume: 3 h 22 min | 4 h 7 min | 2 h 9 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 49 visits sampled | 8 h 16 min | 3 h 54 min | 4 h 17 min |
| Left before being seen Lower is better · 45,450 patients | 2% | 2% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 16 patients | 44% | 70% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 94 patients | 47% | 69% | 65% |
How Ochsner LSU Health Shreveport compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Ochsner LSU Health ShreveportThis hospital | 2/5 | 69% | 4 h 7 min | 4 better |
| CHRISTUS Shreveport-Bossier Health SystemSame city | 3/5 | 71% | 2 h 45 min | 3 better 2 worse |
| Willis Knighton Medical CenterSame city | 3/5 | 72% | 2 h 57 min | 2 better 1 worse |
| Ochsner LSU Health Shreveport-St Mary Medical CentSame city | 2/5 | 75% | — | 1 better |
| Overton Brooks VA Medical Center (shreveport)Same city | 2/5 | 67% | — | 2 worse |
| Specialists Hospital ShreveportSame city | Not rated | 82% | — | 1 better |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Shreveport.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 1,578 cases | Too few cases | 4.2% | 3.9% |
| Heart failure 67 cases | Too few cases | 12.3% | 11.1% |
| Pneumonia 57 cases | Too few cases | 14.2% | 15.2% |
| Stroke 420 cases | Too few cases | 11.1% | 11.9% |
| COPD 32 cases | Too few cases | 8% | 8.6% |
2 more measures had too few cases here to report.
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1.11 likely 0.78 – 1.45 | 1 |
| Deaths after a serious but treatable surgical complication 91 cases | No different | 164.33 per 1,000 likely 120.57 per 1,000 – 208.1 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 3,025 cases | No different | 0.59 per 1,000 likely 0 per 1,000 – 1.29 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 3,331 cases | No different | 0.41 per 1,000 likely 0.19 per 1,000 – 0.63 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 3,282 cases | No different | 0.23 per 1,000 likely 0.03 per 1,000 – 0.43 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 1,132 cases | No different | 2.72 per 1,000 likely 1.3 per 1,000 – 4.15 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 559 cases | No different | 1.85 per 1,000 likely 0.24 per 1,000 – 3.47 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 488 cases | No different | 12.21 per 1,000 likely 4.96 per 1,000 – 19.47 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 1,096 cases | No different | 4.09 per 1,000 likely 2.02 per 1,000 – 6.17 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 500 cases | No different | 5.19 per 1,000 likely 1.49 per 1,000 – 8.9 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 162 cases | No different | 1.64 per 1,000 likely 0.16 per 1,000 – 3.11 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 594 cases | No different | 0.91 per 1,000 likely 0 per 1,000 – 1.92 per 1,000 | 1.06 per 1,000 |
1 more measure had too few cases here to report.
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.91 likely 0.49 – 1.55 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.67 likely 0.38 – 1.09 | 1 |
| Surgical site infections after colon surgery | No different | 2.02 likely 0.99 – 3.71 | 1 |
| MRSA bloodstream infections | No different | 1.44 likely 0.76 – 2.51 | 1 |
| C. diff intestinal infections | Better | 0.12 likely 0.05 – 0.26 | 1 |
1 more measure had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 60 cases | Too few cases | 15.6% | 14.4% |
| Readmitted after heart failure 190 cases | Too few cases | 22.4% | 21.3% |
| Readmitted after pneumonia 105 cases | Too few cases | 17.1% | 17.3% |
| Readmitted after COPD 112 cases | Too few cases | 20.6% | 20% |
| Days back in hospital after heart failure 81 cases | Too few cases | -54.5 days per 100 | — |
| Days back in hospital after pneumonia 61 cases | Too few cases | -16 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 450 cases | No different | 13 per 1,000 likely 9.6 per 1,000 – 17.3 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 122 cases | No different | 9.9 per 100 likely 7.2 per 100 – 13.3 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 122 cases | No different | 5.6 per 100 likely 3.8 per 100 – 8.1 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 222 cases | No different | 1 likely 0.8 – 1.4 | — |
4 more measures had too few cases here to report.
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $93,173
- 2020 $81,987
- 2021 $120,071
- 2022 $188,593
- 2023 $185,320
- 2024 $173,433
- 2025 $147,389
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Debt forgiveness | $53,824 | 19 |
| Medical devices and supplies on long-term loan | $50,410 | 7 |
| Speaking, teaching and other services | $1,375 | 5 |
| Gifts | $450 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Intuitive Surgical, INC. | $48,360 | 7 |
| KLS-Martin L.P. | $42,906 | 13 |
| Takeda Pharmaceuticals U.S.A., Inc. | $35,696 | 5 |
| Fisher Scientific Company L.L.C. | $7,138 | 3 |
| Agios Pharmaceuticals, Inc. | $3,750 | 4 |
| Stryker Corporation | $3,576 | 1 |
| LeMaitre Vascular, Inc. | $2,500 | 1 |
| W. L. Gore & Associates, Inc. | $1,500 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A PHASE-III, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, INTERNATIONAL, MULTICENTRE STUDY TO ASSESS EFFICACY AND SAFETY OF CX601, A… Takeda Pharmaceuticals U.S.A., Inc. · NCT03279081 | $35,156 |
| A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Mitapivat in Subjects With Sickle… Agios Pharmaceuticals, Inc. | $3,750 |
| GREAT Global Registry for Endovascular Aortic Treatment W. L. Gore & Associates, Inc. · NCT01658787 | $1,500 |
| LONG-TERM SAFETY AND TOLERABILITY OF TAK-881 IN SUBJECTS WITH PRIMARY IMMUNODEFICIENCY DISEASES (PIDD) Takeda Pharmaceuticals U.S.A., Inc. | $540 |
| A PHASE 23 INTERVENTIONAL SAFETY PHARMACOKINETICS AND EFFICACY OPENLABEL MULTICENTER SINGLEARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332 NI… PFIZER INC. | $384 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Ochsner LSU Health Shreveport
Is Ochsner LSU Health Shreveport a good hospital?
Ochsner LSU Health Shreveport has a CMS overall rating of 2 out of 5 stars. Of the 21 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on none. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Ochsner LSU Health Shreveport?
69% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 548 completed HCAHPS surveys.
How long is the wait in the Ochsner LSU Health Shreveport emergency room?
Emergency patients spend a median of 4 h 7 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with high patient volume, like this one, the median is 3 h 22 min. 2% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Ochsner LSU Health Shreveport receive money from drug and device companies?
Drug and device makers reported $147,389 in payments to Ochsner LSU Health Shreveport for 2025, under the federal Open Payments program. A payment on its own does not show a conflict of interest.